Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference
2 juni, 22:05
2 juni, 22:05
PR Newswire
BOSTON, June 2, 2026
BOSTON , June 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. ET.
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link:
https://event.webcasts.com/starthere.jsp?ei=1766065&tp_key=0b16b4b62d&tp_special=8
A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com .
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Sr. Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |

SOURCE Haemonetics Corporation

2 juni, 22:05
PR Newswire
BOSTON, June 2, 2026
BOSTON , June 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. ET.
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link:
https://event.webcasts.com/starthere.jsp?ei=1766065&tp_key=0b16b4b62d&tp_special=8
A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com .
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Sr. Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |

SOURCE Haemonetics Corporation

Federal Reserve
Aktieanalys
Stigande räntor
SBB
Valet
Federal Reserve
Aktieanalys
Stigande räntor
SBB
Valet
1 DAG %
Senast
OMX Stockholm 30
0,00%
(vid stängning)
Vostok New Ventures
Idag, 07:55
Stark tillväxt för Voi
Volvo Car
Idag, 07:21
Volvo Cars ska lansera 13 nya bilar
OMX Stockholm 30
1 DAG %
Senast
3 250,63